Final Programme

Postgraduate Educational Programme
A-304 09:00
PET/CT: For which tumors is it the reference standard?
C. Collins; Dublin/IE
Learning Objectives:
1. To state typical indications for FDG-PET/CT in oncology.
2. To summarise reasons for false-positive fi ndings with FDG-PET/CT.
3. To discuss alternative tracers in FDG-PET-negative tumors.
4. To compare PET/CT with other functional and morphological imaging modalities.
A-305 09:25
PET/CT in staging and follow-up of lymphoma
S.F. Barrington; London/UK
Learning Objectives:
1. To discuss typical fi ndings on FDG-PET and CT in patients with lymphoma.
2. To compare treatment response as visualised with FDG-PET/CT and with morphology alone.
3. To learn if PET/CT can be of benefi t in guidance of lesion biopsy compared to CT alone.
Panel discussion 09:50
08:30 - 10:00 Room E1
Musculoskeletal
RC 1310
Soft tissue tumors
Moderator: A.M.A. de Schepper; Antwerp/BE
A-306 08:30
A. Differential diagnosis: How far can we go?
J.L. Bloem, A. de Schepper; Leiden/NL
Learning Objectives:
1. To identify soft tissue tumors that can, or cannot be diagnosed using MRI.
2. To generate and extract information from MRI to make specifi c diagnoses.
3. To differentiate between defi nitely benign and potentially malignant soft tissue tumors using clinical and
radiological information.
A-307 09:00
B. Local staging of sarcomas
K. Wörtler; Munich/DE
Learning Objectives:
1. To understand the clinical importance of local staging in patients with soft tissue sarcomas.
2. To learn to assess local tumor extension, bone involvement, and neurovascular encasement on MR images.
3. To discuss advantages and disadvantages of different MR techniques and to suggest a standardised
examination protocol.
A-308 09:30
C. Post-operative imaging
A.M. Davies; Birmingham/UK
Learning Objectives:
1. To understand the strengths and weaknesses of MR imaging in the follow-up of patients with treated soft
tissue sarcoma.
2. To learn an algorithmic approach to the use of MR imaging in follow-up.
3. To distinguish the MRI features of tumor recurrence from other post operative complications.
216 A B C D European Society of Radiology